Introduction {#sec1}
============

Influenza-like illness (ILI) and influenza outbreaks commonly occur in schools \[[@cit0001],[@cit0002]\], with areas like United Kingdom reporting as many as 658 school respiratory illness outbreaks in one season, with attack rates ranging from 14-45% \[[@cit0003]\]. There are few data describing outbreaks of influenza or ILI in South Africa. To our knowledge, only three outbreaks have been described in peer-reviewed journals. This includes an outbreak of influenza A (H3N2) virus in a police residential college in Pretoria in 2003 with an attack rate of 20-47% \[[@cit0004]\], an outbreak affecting students from several schools in Bophuthatswana in 1978 where the strain was not characterized \[[@cit0005]\], and an outbreak of influenza A (H2N2) virus in gold miners near Johannesburg in 1958 with an attack rate of 15% \[[@cit0006]\].

On the 14^th^ of July 2016, the resident doctor at a boarding school in the Eastern Cape Province, South Africa, contacted the National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS) and reported a large number of students presenting with ILI since the 9^th^ of July, more cases than he had experienced for any influenza season in his time working at the school. Symptoms among students presenting to the sanatorium included fever, cough and generalised body pains. Due to the high number of cases, the disruption of school activities and the unique opportunity to describe an influenza outbreak in a closed population, we conducted an investigation during the 26-29^th^ of July 2016, aimed to confirm the etiological agent, estimate attack rates among students and identify risk factors for illness.

Methods {#sec2}
=======

The investigation took place at a co-educational private school in the Eastern Cape province. Besides South Africans, the nationalities of the students varied and included more than 20 countries.

Interviews were held with the school sanatorium doctor and nurse, the senior school headmaster, head of academics and head of sport to gather information on the setting and the impact of the outbreak on the school. The outbreak was confined mainly to senior school students and therefore the focus of this investigation was on the senior school students (grades 8-12 and bridge year students). Cases were identified from medical record review and questionnaires administered to staff and students.

Cohort study {#sec2.1}
------------

We conducted a cohort study to estimate the attack rate of medically attended ILI (medILI) treated in the school sanatorium. We included all 308 senior school boarding students, but excluded day students as they were more likely to seek private healthcare and we did not have the resources or ethical permission to review records from students at all private practitioners in the town. Cases of medILI from 3 July - 1 August 2016 (start of the school term until end of investigation) were defined as boarding students having a cough and fever as noted on records or extrapolated from prescribed medication, and were identified through a retrospective review of medical records and the admission log at the sanatorium. Fever was defined as either a documented body temperature above 38°C or "fever" noted under symptoms in the medical record. Non-cases were persons who did not meet the medILI case definition. Medical records of 198 patients were reviewed from the senior school boarding population, including all cases of clinician-diagnosed influenza from 3-27 July 2016 (n=82), and a convenience sample of a subset of non-cases (n=116). Age, residence information and influenza vaccination status prior to the outbreak for all boarders were obtained from the school\'s register. Attack rates were calculated by dividing the number of cases of medILI by the specified population. A multivariable logistic regression analysis was conducted to compare the rate of medILI in each subgroup, including all variables that produced a p-value \<0.2 in the univariate analysis. Variables considered in the model were age, gender and boarding house. The vaccine effectiveness against medILI in senior boarders was calculated by determining the adjusted odds ratio (aOR) of medILI in those vaccinated to those not vaccinated and then using the following formula: VE = (1-aOR) x 100.

Cross-sectional study {#sec2.2}
---------------------

We also performed a cross-sectional study to assess the extent of the outbreak and risk factors for illness in a broader population including the day students of the senior school. All senior students (boarding and day) were invited to complete a self-administered, web-based questionnaire which collected information on demographics, travel and medical history, current influenza vaccination status, ILI symptoms and participation in academic, sport and cultural activities in the month prior to the investigation. An epidemiological curve was constructed to include the time period before the start of the term to indicate the baseline level of medILI before the outbreak and the medILI that occurred until the end of the outbreak investigation (25 June - 27 July 2016). Attack rates for self-reported medILI (self-reported cough and fever and seeking medical care from a nurse or clinician) were calculated from the start of the school term (3 July 2016) to when the investigation was performed (27 July 2016) by dividing the number of individuals reporting each condition by the specified population. A multivariable logistic regression analysis compared the proportion reporting medILI in each of the subgroups, assessing all variables with a p-value \<0.2 in the univariate analysis. Variables with a p-value \<0.05 were included in the final analysis. Variables considered in the model were age, grade, gender, nationality, boarding/day student, boarding house, having cubicles in the boarding room, participation in sports and other activities and having underling medical conditions.

Data processing and analysis {#sec2.3}
----------------------------

The web-based questionnaire used in the cross-sectional study was done on the Google forms platform and the output exported to Microsoft Excel 2010 (Microsoft Corporation, Redmond, WA, USA). Data from medical records and the student register collected for the cohort study were captured on the same database. Data were analysed in Stata version 14.0 (StataCorp LLC, College Station, TX, USA).

Laboratory investigations {#sec2.4}
-------------------------

Respiratory specimens were collected by the resident doctor and nurse from a convenient subset of boarding and day senior students clinically diagnosed with influenza from 13 to 29 July 2016. The swabs were transported in universal transport medium to the Centre for Respiratory Diseases and Meningitis, NICD, Johannesburg.

Specimens were tested for virological and bacteriological respiratory pathogens. Isolation of nucleic acid was performed by using MagNA Pure 96 System (Roche Diagnostics, Mannheim, Germany) according to the manufacturer\'s protocol. The first four specimens collected were tested using a real-time reverse-transcription polymerase chain reaction (rtRT-PCR) FTD Respiratory pathogens 21 assay (Fast Track Diagnostics Ltd., Sliema, Malta) for the detection of influenza A viruses, influenza B viruses, rhinoviruses, coronaviruses NL63, 229E, OC43, HKU1, parainfluenza viruses 1,2,3,4, human metapneumovirus A/B, bocavirus, respiratory syncytial virus (RSV) A/B, adenoviruses, enteroviruses, parechoviruses and *Mycoplasma pneumonia*. All subsequent specimens were tested using an rtRT-PCR FTD FLU/HRSV assay (Fast Track Diagnostics Ltd.) to test for influenza type A and B viruses and RSV. Influenza A positive specimens were further subtyped by rtRT-PCR using Centers for Disease Control and Prevention (CDC, Atlanta, Georgia, USA) primers and probes specific for H1N1pdm09 and H3N2 viruses following a previously described protocol \[[@cit0007]\].

Specimens were also tested for eleven bacterial pathogens (*Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Moraxella catarrhalis, Klebsiella pneumoniae, Pseudomonas aeruginosa, Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella spp, Bordetella pertussis and Neisseria meningitides*) using commercial FTD kits (community-acquired pneumonia \[CAP1\] and hospital-acquired pneumonia \[HAP\]; \[Fast Track Diagnostics Ltd.) and in-house real-time PCR kits and assays \[[@cit0008]-[@cit0011]\].

A subset of the laboratory-confirmed influenza A (H3N2) virus specimens (n=19) were sequenced using the Illumina MiSeq platform (Illumina, CA, USA) following enrichment by influenza A virus-specific genome PCR. Genome sequences were assembled using the de novo assembly approach. An amino acid sequence alignment of the complete hemagglutinin (HA) genes excluding the signal peptide for 14 specimens was generated using ClustalW algorithm embedded in BioEdit v7.0.9.1 \[[@cit0012]\]. The multiple sequence alignment of HA genes (1653 base pairs) of the 2016 Southern Hemisphere recommended A (H3N2) vaccine strain (A/Hong Kong/4801/2014) was included as a reference strain and root, together with 42 South African strains from specimens collected in the period 19 May to 8 August 2016 (retrieved from the Global Initiative on Sharing All Influenza Data \[GISAID\] database; [Annex 1](#app1){ref-type="app"}) \[[@cit0013]\]. The South African specimens were obtained through the NICD influenza surveillance programs and shared with the World Health Organization Collaborating Centres for Reference and Research on Influenza at Francis Crick Institute, London, United Kingdom; Victorian Infectious Diseases Reference Laboratory in Melbourne, Australia and the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, USA. A phylogenetic tree was generated by the maximum likelihood method employing the Hasegawa-Kishino-Yano (HKY) evolutionary model in the MEGA (Molecular Evolutionary Genetics Analysis) \[[@cit0014]\] version 6 program. To determine confidence for support of the branches, 500 bootstrap replicates were employed.

Ethical considerations {#sec2.5}
----------------------

Prior to the investigation, guidance on managing parental consent for this outbreak investigation was sought from the chairperson of the Human Research Ethics Committee (Medical) of the University of the Witwatersrand. The investigation was covered by the clearance certificate for Essential Communicable Diseases Surveillance and Outbreak response investigation activities of the NICD from the Human Research Ethics Committee (Medical) of the University of the Witwatersrand, reference M160667. Permission was obtained from the Eastern Cape Department of Health (EC-2017RP52_694). Informed consent and assent were obtained from parents and students to complete the questionnaires in the cross-sectional study. All information collected was linked to an anonymised study identification number. The raw data were only accessed by the researcher doing the analysis, which was done on a password-protected computer.

Results {#sec3}
=======

Setting {#sec3.1}
-------

The school employed a nurse and offered primary health care services for boarders and day students. A school doctor consulted when required. The school annually offered the Southern Hemisphere influenza vaccine to consenting students as soon as the vaccine was available in South Africa, which was billed to the student\'s medical aid.

The senior school hosted grade 8 to 12 as well as bridge year students. The bridging year offered students that finished grade 12 an additional year of school before starting tertiary education. There were 427 senior students of which 308 (72%) were boarders, aged 12-19 years. The senior school had four hostels for boys situated on the main campus, housing between 36-45 boys each. There were two hostels for girls each accommodating 59 and 76 students, situated within walking distance from the main campus. There was also a house allocated to female day students, while the male day students were divided amongst the male boarding houses. Day students spent time in these houses between classes and sports activities. The bridge year students had a separate hostel.

Initially, students presenting to the school sanatorium with ILI were admitted to the sick bay which could host 18 individuals, to allow for isolation and to prevent further spread of the virus. When the sanatorium reached capacity, symptomatic students were encouraged to stay within their rooms in the boarding house and to practise good hand hygiene. Alcohol-based hand sanitizer was made available throughout the boarding houses with signs to encourage usage.

It was recommended that symptomatic students not participate in any sporting events, and from 11-24 July there were multiple students that did not attend sports practice due to illness. Several sports events and practices were cancelled. The sports program recommenced on 25 July. Except for sports practices and matches, many other meetings and cultural events had to be rescheduled or cancelled. Although academic classes were not cancelled during the outbreak, remedial days had to be held after the outbreak for students to catch up on their work.

Cohort study {#sec3.2}
------------

We identified 39 medILI cases occurring between 5-27 July ([Figure 1](#f0001){ref-type="fig"}). The attack rate of medILI ([Table 1](#t0001){ref-type="table"}) amongst senior boarders was 13% (39/308). There were no significant differences in attack rates by age group, gender or residence. Of 308 boarders, 19% (n=57) were vaccinated prior to the outbreak. Additional vaccinations were not provided during the outbreak. After adjusting for gender, the vaccine effectiveness against medILI was 18% (aOR 0.82, 95%CI 0.38-1.78). Only two cases resulted in complications. There was one hospitalization reported when a student fainted at an event and one case of suspected pneumonia; both students recovered.

###### 

Description of boarders, medically attended influenza-like illness cases and analysis of potential risk factors for medILI

                          Attack rate n/N (%)   Univariate analysis                       
  ----------------------- --------------------- --------------------- ------------ ------ ----
  **Gender**              Males                 18/171(10.5)          1            \-     \-
  Females                 21/137(15.3)          1.24                  0.78-3.02    0.21   
  **Age**                 ≤15                   13/123(10.5)          1            \-     \-
  \>15                    26/185(14.1)          1.41                  0.69-2.85    0.36   
  **Residence**           Male residence 1      3/41(7.3)             1            \-     \-
  Male residence 2        4/42(9.5)             1.30                  0.27-6.20    0.74   
  Male residence 3        8/45(17.8)            2.67                  0.66-10.84   0.72   
  Male residence 4        3/35(8.6)             1.16                  0.22-6.13    0.87   
  Female residence 1      13/76(13.2)           1.87                  0.48-7.22    0.37   
  Female residence 2      11/58(19.0)           2.89                  0.75-11.11   0.12   
  Bridge year residence   0/11(0)               0                     \-           \-     

+Crude odds ratios displayed. Logistic regression not performed as no factors were significantly associated with medILI

![Epidemic curve of medically attended influenza-like illness (ILI, n=39) in senior school boarders in cohort study](PAMJ-33-42-g001){#f0001}

Cross-sectional study in students {#sec3.3}
---------------------------------

Of 427 students invited to complete the questionnaire, 36% (n=152) participated. Responses included 35% (107/308) of the boarders and 38% (45/119) of day students. Thirty-six cases were identified from 25 June - 27 July 2016, 30 cases within the outbreak period, attack rate 20% ([Figure 2](#f0002){ref-type="fig"}).

![Epidemic curve of self-reported medically attended influenza-like illness (ILI, n=36) in senior school students in cross-sectional study](PAMJ-33-42-g002){#f0002}

On multivariable analysis, playing squash (aOR 5.35, 95%CI 1.68-17.07) and being in grade 8 (aOR 6.84 p=0.05) were significantly associated with medILI ([Table 2](#t0002){ref-type="table"}).

###### 

Description of students that participated in cross-sectional study, attack rates of medically attended influenza-like illness(medILI) and potential risk factors for medILI

                                                             Attack rate n/N(%)                                     Univariate analysis   Multivariable analysis                                                             
  ---------------------------------------------------------- ------------------------------------------------------ --------------------- ------------------------ ------------ ---------- ---------------- ---------------- ----------
  Age                                                        ≤15                                                    9/53(17)              1                        \-           \-         \-               \-               \-
  \> 15                                                      21/99(21)                                              1.27                  0.53-3.05                0.586        \-         \-               \-               
  Grade                                                      8                                                      5/17(29)              5.21                     0.88-30.84   0.07       **6.84**         **1.03-45.26**   **0.05**
  9                                                          2/27(7)                                                1                     \-                       \-           1          \-               \-               
  10                                                         4/27(15)                                               2.17                  0.36-13.01               0.40         1.68       0.26-10.82       0.58             
  11                                                         10/40(25)                                              4.17                  0.83-20.87               0.08         4.47       0.82-24.46       0.08             
  12                                                         8/36(22)                                               3.57                  0.69-18.42               0.13         3.54       0.64-19.70       0.15             
  Bridge year                                                1/4(25)                                                4.17                  0.28-60.93               0.30         5.49       0.31-95.98       0.31             
  Gender                                                     Female                                                 19/76(25)             1.97                     0.86-4.49    0.107      2.34             0.92-5.98        0.07
  Male                                                       11/76(14)                                              1                     \-                       \-           1          \-               \-               
  Nationality                                                South African                                          23/114(20)            1.04                     0.41-2.69    0.924      \-               \-               \-
  Non-SA                                                     7/36(19)                                               1                     \-                       \-           \-         \-               \-               
  Boarding                                                   Day student                                            9/45(20)              1.02                     0.43-2.45    0.958      \-               \-               \-
  Boarder                                                    21/107(20)                                             1                     \-                       \-           \-         \-               \-               
  House                                                      Male res 1                                             0/11(0)               0                        \-           \-         \-               \-               \-
  Male res 2                                                 3/13(23)                                               1.20                  0.24-6.06                0.825        \-         \-               \-               
  Male res 3                                                 4/20(20)                                               1.00                  0.22-4.35                1.000        \-         \-               \-               
  Male res 4                                                 1/12(8)                                                0.36                  0.04-3.52                0.382        \-         \-               \-               
  Female Res1                                                8/23(35)                                               2.13                  0.28-7.85                0.254        \-         \-               \-               
  Female res 2                                               5/25(20)                                               1                     \-                       \-           \-         \-               \-               
  Female day res                                             6/27(22)                                               1.14                  0.30-4.34                0.845        \-         \-               \-               
  BY res                                                     0/3(0)                                                 0                     \-                       \-           \-         \-               \-               
  Cubicles                                                   No                                                     13/54(24)             2.15                     0.70-6.66    0.182      \-               \-               \-
  Yes                                                        5/39(13)                                               1                     \-                       \-           \-         \-               \-               
  Sport[^a^](#tf2-1){ref-type="table-fn"}                    Athletics                                              2/22(1)               0.36                     0.79-1.64    0.186      \-               \-               \-
  No athletics                                               28/129(22)                                             1                     \-                       \-           \-         \-               \-               
  Basketball                                                 3/16(19)                                               0.71                  0.19-2.66                0.615        \-         \-               \-               
  No basketball                                              27/135(20)                                             1                     \-                       \-           \-         \-               \-               
  Cricket                                                    3/35(9)                                                0.31                  0.06-1.77                0.163        \-         \-               \-               
  No cricket                                                 8/40(20)                                               1                     \-                       \-           \-         \-               \-               
  Hockey                                                     18/92(20)                                              0.95                  0.42-2.16                0.907        \-         \-               \-               
  No hockey                                                  12/59(20)                                              1                     \-                       \-           \-         \-               \-               
  Netball                                                    10/43(23)                                              0.81                  0.25-2.64                0.689        \-         \-               \-               
  No netball                                                 9/33(27)                                               1                     \-                       \-           \-         \-               \-               
  Rugby                                                      4/42(10)                                               0.39                  0.08-1.74                0.156        \-         \-               \-               
  No rugby                                                   7/33(21)                                               1                     \-                       \-           \-         \-               \-               
  Squash                                                     8/22(36)                                               **2.78**              **1.04-7.42**            **0.041**    **5.35**   **1.68-17.07**   **0.005**        
  No squash                                                  22/129(17)                                             1                     \-                       \-           1          \-               \-               
  Swimming                                                   1/13(8)                                                0.31                  0.04-2.51                0.274        \-         \-               \-               
  No swimming                                                29/38(21)                                              1                     \-                       \-           \-         \-               \-               
  Tennis                                                     9/32(28)                                               1.83                  0.74-4.51                0.191        \-         \-               \-               
  No tennis                                                  21/119(18)                                             1                     \-                       \-           \-         \-               \-               
  Water polo                                                 11/41(27)                                              1.76                  0.75-4.11                0.194        \-         \-               \-               
  No water polo                                              19/110(17)                                             1                     \-                       \-           \-         \-               \-               
  Other Activities[^a^](#tf2-1){ref-type="table-fn"}         Cheering                                               11/53(21)             1.09                     0.47-2.50    0.841      \-               \-               \-
  No cheering                                                19/98(19)                                              1                     \-                       \-           \-         \-               \-               
  Drama                                                      4/21(20)                                               0.94                  0.29-3.04                0.919        \-         \-               \-               
  No drama                                                   26/130(20)                                             1                     \-                       \-           \-         \-               \-               
  Music                                                      9/27(30)                                               2.45                  0.97-6.20                0.058        \-         \-               \-               
  No music                                                   21/124(17)                                             1                     \-                       \-           \-         \-               \-               
  Medical History                                            Underlying illness[^b^](#tf2-2){ref-type="table-fn"}   7/35(20)              1                        \-           \-         \-               \-               \-
  No under-lying illness[^b^](#tf2-2){ref-type="table-fn"}   23/117(20)                                             0.98                  0.38-2.52                0.964        \-         \-               \-               
  Asthma                                                     Asthma                                                 5/31(16)              1                        \-           \-         \-               \-               \-
  No asthma                                                  25/120(21)                                             1.37                  0.47-3.92                0.560        \-         \-               \-               

**OR** -- Odds ratio, **CI** -- confidence interval. Final logistic regression model included gender, grade and squash participation. Reference group underlined.

For most factors, characteristics were mutually exclusive and associations were calculated in comparison with group underlined. For sport and other activities, associations were calculated individually for each sport/activity(participating vs. not participating) as students participate in multiple sports/activities and groups are therefore not mutually exclusive.

Underlying illness includes asthma, epilepsy and diabetes.

Of 152 students who completed the questionnaire, 116 days of school were missed due to absenteeism caused by ILI. Among students, 33% (n=50) missed school, 29% (n=44) missed study time, 45% (n=68) missed sport and 14% (n=21) missed other events or time with their friends. The mean time missed from school was 3.4 days per ill student (range 1-11 days). Thirty percent (n=45) of students that completed the questionnaire reportedly received the 2016 vaccine before the outbreak. The reasons provided for not receiving the vaccine are shown in [Table 3](#t0003){ref-type="table"}.

###### 

Reasons cited for not getting vaccinated for influenza

                                                         n    \%
  ------------------------------------------------------ ---- ------
  People still fall ill after they receive the vaccine   40   26.3
  I do not like needles                                  27   17.8
  My parents said I didn't need to                       26   17.1
  It will make me sick                                   20   13.2
  I am not at risk for severe influenza                  14   9.2
  It will be painful                                     6    4
  It is expensive                                        3    2
  Vaccinations are unsafe                                2    1.3
  I did not get the opportunity                          0    0

Laboratory investigations {#sec3.4}
-------------------------

Of the first four nasal specimens collected before the outbreak investigation, influenza A viruses were detected in all, while all tests for all other pathogens in a 21-plex respiratory pathogens assay were negative. A further 34 respiratory specimens collected (27 nasopharyngeal and 7 throat swabs) from day and boarding students were tested as part of the investigation. Of all the specimens collected (n=38), 23 (61%) tested positive for influenza A (H3N2) viruses. No influenza B viruses or RSV were detected. Results from bacteriological investigations are shown in [Figure 3](#f0003){ref-type="fig"}. Due to sample volume constraints, only 33 specimens were tested for *N. meningitides*. Thirteen of the 38 specimens (34%) were collected from individuals that did not meet the medILI case definition, 9 of which tested positive for influenza A (H3N2) virus.

![Real-time PCR results for bacterial and viral pathogens tested for in the respiratory specimens collected (n=38)](PAMJ-33-42-g003){#f0003}

On molecular analysis, South African influenza A (H3N2) virus HA gene sequences from the 2016 influenza season formed at least 5 genetic clusters (with geographic clustering pattern) supported by bootstrap values of 98-100% and belong to the 3C.2a genetic clade ([Figure 4](#f0004){ref-type="fig"}). All HA genes from influenza A (H3N2) viruses identified in the school outbreak were in the genetic cluster characterised by the following amino acid mutations when compared to the 2016 vaccine strain: N171K, I406V and G484E. The outbreak strains formed a distinct highly homogeneous monophyletic sub-cluster with 99% bootstrap support characterised by N121K, I140M and G479E substitutions when compared to the vaccine strain. Included in the outbreak sub-cluster was a single H3N2 virus originally identified in an individual from the Western Cape Province collected in week 24 of the 2016 season trough routine surveillance. All outbreak specimens were collected in weeks 28 to 30. This Eastern Cape Province lineage was distinguished from the A/Hong Kong/4801/2014 vaccine strain by a total of 9 amino acid mutations including the aforementioned and following mutations in the deduced HA amino acid sequences (excluding signal peptide): S96N, K160T and P194L. These 9 mutations are characteristic of the recently emerged 3C.2a1 sub-lineage. All other South African viruses used as reference belong, like the vaccine strain, to clade 3C.2a.

![Maximum likelihood phylogenetic tree of the haemagglutinin (HA) gene for 14 of the outbreak specimens (●), 45 South African surveillance and the H3N2 vaccine strain (∎/Hong Kong/4801/2014), South Africa, 2016](PAMJ-33-42-g004){#f0004}

Discussion {#sec4}
==========

The outbreak occurred from 9-28 July based on the epidemiological curve and the last samples that tested positive for influenza A (H3N2) virus. Laboratory testing identified influenza A (H3N2) virus as the etiological agent with an overall high attack rate of medILI (13% in cohort and 20% in cross-sectional study), with participating in the sport squash being the strongest risk factor associated with medILI. Multiple sporting and cultural events were cancelled during the outbreak and academic remedial sessions were rescheduled afterwards.

There are several non-influenza viruses that can cause ILI, as well as some bacterial pathogens, although bacterial aetiologies for ILI are rare \[[@cit0015]\]. The most common pathogens isolated in non-influenza virus ILI include rhinoviruses, parainfluenza viruses, respiratory syncytial virus, human metapneumovirus, adenoviruses and coronaviruses \[[@cit0016],[@cit0017]\], none of which were identified during laboratory testing of the specimens. Although bacterial pathogens were detected in some samples, levels were consistent with colonization of the respiratory tract; therefore, it was difficult to determine causation \[[@cit0018],[@cit0019]\].

Closed spaces facilitate the spread of influenza viruses since they are transmitted by droplets and aerosols from infected people when coughing or sneezing \[[@cit0020]\]. A modelling study by Glass *et al.* among school-aged children predicted that social interactions with friends, attending school lectures, and participating in sports were some of the most important factors for influenza transmission \[[@cit0021]\]. This may be the cause for the association of medILI with playing squash. The sport takes place in a confined space leading to participants being in close proximity. Squash is an aerobic sport with associated increases in the heart and respiratory rate. Studies have shown that strenuous exercise can lead to the suppression of the immune system and make individuals more vulnerable to infections, especially of the upper respiratory tract \[[@cit0022],[@cit0023]\]. Studies have also shown that individuals may start shedding the virus and become infective up to two days prior to showing symptoms \[[@cit0024]\]. Asymptomatic shedding may lead to higher levels of transmission.

There was low influenza vaccine coverage for the 2016 season amongst the boarders (18%). Since senior school students and boarding school residents are not listed under the priority groups for influenza vaccination in South Africa \[[@cit0025]\] the low vaccination coverage is not unexpected. The school does have an influenza vaccination program that encourages vaccination; however, parents and students decide whether or not to be vaccinated. The main reasons students were not vaccinated was the perception that the vaccine doesn\'t work, being afraid of needles and because parents did not encourage students to be vaccinated.

The VE against medILI in this study was 18%, in keeping with results from national influenza surveillance. The South African national VE estimates against laboratory-confirmed influenza for the 2016 Southern Hemisphere season for all influenza subtypes was 18% (95%CI minus 55%-60%), and 0.4% (95%CI minus 124%-56%) against influenza A (H3N2) viruses \[[@cit0026]\]. The influenza strain that circulated during this outbreak may have undergone antigenic drift from the vaccine strain leading to reduced protection, but antigenic data were unavailable. Genome sequencing of the strains did indicate some mutations from the vaccine strain, but these mutations would not necessarily translate to a reduction in vaccine effectiveness. The clonal nature of the viruses characterised together with its distinct geographic clustering strongly support the thought that an H3N2 virus from an initial sentinel case may be the cause of the outbreak in this closed school setting.

Despite the low vaccine effectiveness observed, there is overwhelming evidence from the literature indicating that influenza vaccination effectively prevents influenza. Prior studies have shown that influenza vaccination programs in boarding schools can reduce the attack rate of ILI by 50% \[[@cit0027]\]. Since complications due to influenza rarely arise in healthy school-going children \[[@cit0028]\], reasons to encourage vaccination in this population should focus on reducing the disruption to academic and sports programs by reducing absenteeism \[[@cit0029]\] and the indirect effect on reducing the community acquisition of the virus by preventing the amplification of transmission in schools \[[@cit0030],[@cit0031]\]. To prevent transmission of influenza in schools and other settings, it is recommended that individuals with ILI symptoms not attend work or school until at least 24 hours after fever subsides. Students, parents and staff should be educated on the differences between a common cold and influenza to ensure that health care is sought if they experience ILI. Furthermore, one should avoid close contacts; limit visitors; wash hands with soap and water or use an alcohol-based hand rub regularly; and wipe down regularly touched surfaces with a disinfectant. Lastly, it is important to practice good respiratory etiquette by covering the mouth and nose with a tissue when coughing or sneezing \[[@cit0032]\]. Schools should have an outbreak management plan in place to be able to detect when the number of cases exceeds the normal seasonal number for early outbreak detection and have a contingency plan in place if this occurs. This plan should include procedures on how and where to isolate symptomatic students, how to record all cases and how to effectively communicate to staff, students and their parents to ensure cooperation and prevent anxiety.

This study had limitations. The low number of cases contributed to low precision of the VE estimate. We employed a broad case definition and an outcome of laboratory-confirmed influenza would have been more specific but reduced the number of cases available for analysis as not all cases were laboratory tested. The higher attack rate observed in the cross-sectional study may be due to the use of self-reported symptoms and not physician indicate symptoms as in the cohort study. The impact of the outbreak might not be completely represented when using the medically attended ILI case definition as described by WHO which relies on the presence of a fever and cough \[[@cit0033]\]. There were several cases of clinically diagnosed influenza identified through medical record review that did not meet our case definition; mostly due to the absence of a cough. A recent transmission study in Hong Kong showed that 41% of individuals who tested positive for influenza did not present with fever, cough or sore throat, which was the WHO case definition for ILI prior to 2014 \[[@cit0024]\]. We had a low response rate (36%) in the cross-sectional study. This was influenced by lack of interest among some students and by lack of parental consent for others. This may have resulted in participation bias where students that were not affected by ILI might have been less likely to participate, inflating the attack rate of ILI in the cross-sectional study. The attack rate for medILI in the cohort study may therefore be a more accurate representation of the outbreak.

Conclusion {#sec5}
==========

We confirmed an outbreak of influenza A (H3N2) virus in a boarding school possibly initiated by a sentinel case after the return of students from a half-term break. The outbreak impacted academic, cultural and sports activities at the school. Playing squash was associated with medically attended influenza-like illness. Participation in sports activities and attending social gatherings in confined spaces should be discouraged when showing ILI symptoms to prevent infection. Seasonal influenza vaccination should be encouraged in boarding schools to prevent influenza and reduce academic and sports program disruption.

What is known about this topic {#sec5.1}
------------------------------

-   Influenza-like illness (ILI) and influenza outbreaks commonly occur in schools and can disrupt educational activities;

-   There are few data describing outbreaks of influenza or ILI in South Africa.

What this study adds {#sec5.2}
--------------------

-   Outbreaks of influenza in schools may have high attack rates and disrupt educational and extracurricular activities;

-   Participation in sport activities while infected with influenza A viruses may lead to further spread;

-   The most common reason students were not vaccinated was the perception that the vaccine doesn\'t work.
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Sequences information of multiple sequence alignment of HA genes used in the construction of [Figure 4](#f0004){ref-type="fig"}

  Segment ID   Segment   Country           Collection date   Isolate name                     Originating Lab     Submitting Lab                                                     Authors
  ------------ --------- ----------------- ----------------- -------------------------------- ------------------- ------------------------------------------------------------------ ----------------------------------------------------------
  EPI859059    HA        South Africa      2016-Aug-08       A/South- Africa/VW0105/2016      Sandringham, NICD   Crick Worldwide Influenza Centre                                   
  EPI859055    HA        South Africa      2016-Jul-20       A/South- Africa/R5063/2016       Sandringham, NICD   Crick Worldwide Influenza Centre                                   
  EPI859053    HA        South Africa      2016-Jul-19       A/South- Africa/R5036/2016       Sandringham, NICD   Crick Worldwide Influenza Centre                                   
  EPI859051    HA        South Africa      2016-Jul-19       A/South- Africa/R5034/2016       Sandringham, NICD   Crick Worldwide Influenza Centre                                   
  EPI829365    HA        South Africa      2016-Jul-21       A/South- Africa/VW0073/2016      Sandringham, NICD   Crick Worldwide Influenza Centre                                   
  EPI829363    HA        South Africa      2016-Jul-21       A/South- Africa/VW0071/2016      Sandringham, NICD   Crick Worldwide Influenza Centre                                   
  EPI829361    HA        South Africa      2016-Jul-20       A/South- Africa/VW0067/2016      Sandringham, NICD   Crick Worldwide Influenza Centre                                   
  EPI829359    HA        South Africa      2016-Jul-16       A/South- Africa/VW0060/2016      Sandringham, NICD   Crick Worldwide Influenza Centre                                   
  EPI829357    HA        South Africa      2016-Jul-04       A/South- Africa/VW0050/2016      Sandringham, NICD   Crick Worldwide Influenza Centre                                   
  EPI829355    HA        South Africa      2016-Jun-30       A/South- Africa/VW0048/2016      Sandringham, NICD   Crick Worldwide Influenza Centre                                   
  EPI829353    HA        South Africa      2016-Jul-06       A/South- Africa/R4626/2016       Sandringham, NICD   Crick Worldwide Influenza Centre                                   
  EPI829351    HA        South Africa      2016-Jul-05       A/South- Africa/R4598/2016       Sandringham, NICD   Crick Worldwide Influenza Centre                                   
  EPI829349    HA        South Africa      2016-Jun-27       A/South- Africa/R4140/2016       Sandringham, NICD   Crick Worldwide Influenza Centre                                   
  EPI824100    HA        South Africa      2016-Jun-04       A/South                          Sandringham,        Crick Worldwide                                                    
                                                             Africa/VW0036/2016               NICD                Influenza Centre                                                   
  EPI824098    HA        South Africa      2016-Jun-14       A/South Africa/R3978/2016        Sandringham, NICD   Crick Worldwide Influenza Centre                                   
  EPI824096    HA        South Africa      2016-Jun-17       A/South Africa/R3915/2016        Sandringham, NICD   Crick Worldwide Influenza Centre                                   
  EPI824094    HA        South Africa      2016-Jun-13       A/South Africa/R3703/2016        Sandringham, NICD   Crick Worldwide Influenza Centre                                   
  EPI824092    HA        South Africa      2016-Jun-08       A/South Africa/R3620/2016        Sandringham, NICD   Crick Worldwide Influenza Centre                                   
  EPI824090    HA        South Africa      2016-Jun-06       A/South Africa/R3412/2016        Sandringham, NICD   Crick Worldwide Influenza Centre                                   
  EPI824088    HA        South Africa      2016-Jun-02       A/South Africa/R3328/2016        Sandringham, NICD   Crick Worldwide Influenza Centre                                   
  EPI824086    HA        South Africa      2016-May-30       A/South Africa/R3142/2016        Sandringham, NICD   Crick Worldwide Influenza Centre                                   
  EPI824084    HA        South Africa      2016-May-26       A/South Africa/R3026/2016        Sandringham, NICD   Crick Worldwide Influenza Centre                                   
  EPI836885    HA        South Africa      2016-Jun-27       A/South Africa/R4203/2016        Sandringham, NICD   WHO Collaborating Centre for Reference and Research on Influenza   Deng,Y-M.; Iannello,P.; Spirason,N.; Lau,H.; Komadina,N.
  EPI836882    HA        South Africa      2016-Jul-06       A/South Africa/Vw0052/2016       Sandringham, NICD   WHO Collaborating Centre for Reference and Research on Influenza   Deng,Y-M.; Iannello,P.; Spirason,N.; Lau,H.; Komadina,N.
  EPI836879    HA        South Africa      2016-Jun-21       A/South Africa/Vw0044/2016       Sandringham, NICD   WHO Collaborating Centre for Reference and Research on Influenza   Deng,Y-M.; Iannello,P.; Spirason,N.; Lau,H.; Komadina,N.
  EPI836876    HA        South Africa      2016-Jul-06       A/South Africa/R4620/2016        Sandringham, NICD   WHO Collaborating Centre for Reference and Research on Influenza   Deng,Y-M.; Iannello,P.; Spirason,N.; Lau,H.; Komadina,N.
  EPI836873    HA        South Africa      2016-Jun-30       A/South Africa/R4336/2016        Sandringham, NICD   WHO Collaborating Centre for Reference and Research on             Deng,Y-M.; Iannello,P.; Spirason,N.; Lau,H.;
                                                                                                                  Influenza                                                          Komadina,N.
  EPI836870    HA        South Africa      2016-Jun-06       A/South Africa/Vw0037/2016       Sandringham, NICD   WHO Collaborating Centre for Reference and Research on Influenza   Deng,Y-M.; Iannello,P.; Spirason,N.; Lau,H.; Komadina,N.
  EPI831849    HA        South Africa      2016-Jul-06       A/South Africa/R4564/2016        Sandringham, NICD   WHO Collaborating Centre for Reference and Research on Influenza   
  EPI831846    HA        South Africa      2016-Jun-27       A/South Africa/R4138/2016        Sandringham, NICD   WHO Collaborating Centre for Reference and Research on Influenza   
  EPI831843    HA        South Africa      2016-Jun-02       A/South Africa/R3334/2016        Sandringham, NICD   WHO Collaborating Centre for Reference and Research on Influenza   
  EPI831840    HA        South Africa      2016-May- 30      A/South Africa/R3157/2016        Sandringham, NICD   WHO Collaborating Centre for Reference and Research on Influenza   
  EPI861614    HA        South Africa      2016-Jul-06       A/South Africa/4639/2016         Sandringham, NICD   Centers for Disease Control and Prevention                         
  EPI861606    HA        South Africa      2016-Jun-29       A/South Africa/4363/2016         Sandringham, NICD   Centers for Disease Control and Prevention                         
  EPI861598    HA        South Africa      2016-Jun-23       A/South Africa/4069/2016         Sandringham, NICD   Centers for Disease Control and Prevention                         
  EPI858452    HA        South Africa      2016-Jul-25       A/South Africa/5233/2016         Sandringham, NICD   Centers for Disease Control and Prevention                         
  EPI858444    HA        South Africa      2016-Jul-25       A/South Africa/5232/2016         Sandringham, NICD   Centers for Disease Control and Prevention                         
  EPI858436    HA        South Africa      2016-Jul-25       A/South Africa/5231/2016         Sandringham, NICD   Centers for Disease Control and Prevention                         
  EPI858428    HA        South Africa      2016-Jul-19       A/South Africa/5035/2016         Sandringham, NICD   Centers for Disease Control and Prevention                         
  EPI858420    HA        South Africa      2016-Jul-19       A/South                          Sandringham,        Centers for Disease                                                
                                                             Africa/5034/2016                 NICD                Control and Prevention                                             
  EPI858412    HA        South Africa      2016-Jul-16       A/South Africa/5008/2016         Sandringham, NICD   Centers for Disease Control and Prevention                         
  EPI858404    HA        South Africa      2016-Jul-18       A/South Africa/5002/2016         Sandringham, NICD   Centers for Disease Control and Prevention                         
  EPI858396    HA        South Africa      2016-Jul-18       A/South Africa/5000/2016         Sandringham, NICD   Centers for Disease Control and Prevention                         
  EPI834466    HA        South Africa      2016-Jun-30       A/South Africa/3892/2016         Sandringham, NICD   Centers for Disease Control and Prevention                         
  EPI829850    HA        South Africa      2016-Jul-13       A/South Africa/4940/2016         Sandringham, NICD   Centers for Disease Control and Prevention                         
  EPI827416    HA        South Africa      2016-Jun-14       A/South Africa/3731/2016         Sandringham, NICD   Centers for Disease Control and Prevention                         
  EPI827362    HA        South Africa      2016-Jun-29       A/South Africa/4363/2016         Sandringham, NICD   Centers for Disease Control and Prevention                         
  EPI827300    HA        South Africa      2016-Jul-18       A/South Africa/4993/2016         Sandringham, NICD   Centers for Disease Control and Prevention                         
  EPI827292    HA        South Africa      2016-Jul-18       A/South Africa/4990/2016         Sandringham, NICD   Centers for Disease Control and Prevention                         
  EPI827284    HA        South Africa      2016-Jul-18       A/South Africa/4989/2016         Sandringham, NICD   Centers for Disease Control and Prevention                         
  EPI827276    HA        South Africa      2016-Jul-13       A/South Africa/4938/2016         Sandringham, NICD   Centers for Disease Control and Prevention                         
  EPI827269    HA        South Africa      2016-Jul-06       A/South Africa/4639/2016         Sandringham, NICD   Centers for Disease Control and Prevention                         
  EPI827253    HA        South Africa      2016-Jun-27       A/South Africa/4146/2016         Sandringham, NICD   Centers for Disease Control and Prevention                         
  EPI827245    HA        South Africa      2016-Jun-23       A/South Africa/4069/2016         Sandringham, NICD   Centers for Disease Control and Prevention                         
  EPI813929    HA        South Africa      2016-Jun-13       A/South Africa/3743/2016         Sandringham, NICD   Centers for Disease Control and Prevention                         
  EPI813921    HA        South Africa      2016-Jun-20       A/South Africa/3913/2016         Sandringham, NICD   Centers for Disease Control and Prevention                         
  EPI813913    HA        South Africa      2016-Jun-16       A/South Africa/3776/2016         Sandringham, NICD   Centers for Disease Control and Prevention                         
  EPI813905    HA        South Africa      2016-Jun-13       A/South                          Sandringham,        Centers for Disease                                                
                                                             Africa/3680/2016                 NICD                Control and Prevention                                             
  EPI813897    HA        South Africa      2016-Jun-06       A/South Africa/3437/2016         Sandringham, NICD   Centers for Disease Control and Prevention                         
  EPI813889    HA        South Africa      2016-Jun-02       A/South Africa/3285/2016         Sandringham, NICD   Centers for Disease Control and Prevention                         
  EPI813881    HA        South Africa      2016-May-19       A/South Africa/2843/2016         Sandringham, NICD   Centers for Disease Control and Prevention                         
  EPI741474    HA        Hong Kong (SAR)   2016-Apr-22       A/Hong Kong/4801/2014 (15/192)                       National Institute for Biological Standards and Control (NIBSC)    Nicolson, Carolyn
